CVE-2023-6078: Dassault Systèmes BIOVIA Materials Studio products · OS Command Injection
Affects Dassault Systèmes BIOVIA Materials Studio productsSource CVE Database V5
Not known to be exploited · CVSS 8.8 High.
Data as of 26 Oct 2026, 17:16 UTC
- EPSS
- 1.6% chance of exploitation in 30 days – higher than 76% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:HExploitation evidence
Disclosed: evidence found.
CVE published 1 Feb 2024
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.
What to do
AI-suggested
- Immediate Restriction of Access: Limit access to BIOVIA Materials Studio installations to trusted users only, enforcing strict role-based access controls to minimize the number of users with privileges capable of uploading scripts.
- Network Segmentation: Isolate systems running BIOVIA Materials Studio from broader enterprise networks to contain potential compromises and prevent lateral movement.
- Input Validation and Monitoring: Implement application-layer controls to detect and block uploads of suspicious or unauthorized script files, especially Perl scripts.
- Privilege Management: Review and minimize user privileges on affected systems to the least necessary, reducing the risk of exploitation.
- Incident Detection: Deploy host-based and network-based intrusion detection systems tuned to identify unusual command execution patterns or script uploads related to BIOVIA.
- Vendor Coordination: Engage with Dassault Systèmes for timely updates and patches; monitor official channels for patch releases and apply them promptly once available.
- Temporary Workarounds: If feasible, disable or restrict the script upload functionality until a patch is applied.
- Security Awareness: Train users on the risks of uploading untrusted scripts and the importance of following security policies. These measures, combined, will reduce the attack surface and mitigate the risk until a vendor patch is released.
Description
An OS Command Injection vulnerability exists in BIOVIA Materials Studio products from Release BIOVIA 2021 through Release BIOVIA 2023. Upload of a specially crafted perl script can lead to arbitrary command execution.